Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

112.71 -0.26 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,409,746
Open 112.90
Bid (Size) 111.77 (1)
Ask (Size) 112.77 (2)
Prev. Close 112.97
Today's Range 111.28 - 113.30
52wk Range 77.74 - 121.83
Shares Outstanding 1,253,809,440
Dividend Yield 2.80%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles
September is historically the worst month for stocks, but these 10 S&P 500 companies have consistently delivered gains. 
Via Benzinga
Topics Stocks
Veeva Makes A Bearish Move On One Pockmark In Its Quarterly Report
The company beat second-quarter expectations, with the exception of one key metric. 
Via Investor's Business Daily

Performance

YTD
+22.7%
+22.7%
1 Month
-1.6%
-1.6%
3 Month
+3.1%
+3.1%
6 Month
-1.8%
-1.8%
1 Year
+41.4%
+41.4%

More News

Read More
Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump
Via Investor's Business Daily
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
Via Investor's Business Daily
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
Via Stocktwits
Topics Fraud
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
From Gilead Sciences, Inc.
Via Business Wire
Options Corner: Why The Market Could Be Prescribing A Bull Call Spread For Gilead Sciences
Via Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.
Via Investor's Business Daily
Topics ETFs Government Intellectual Property
Market Monitor News August 22 BMO - Coty Crumbles, Powell Looms: Wall Street Cautious Amid Mixed Signals
Via Chartmill
Topics Economy
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
Via Benzinga
Why Gilead Sciences (GILD) Shares Are Sliding Today
Via StockStory
Topics Earnings
These S&P500 stocks are gapping in today's session
Via Chartmill
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Via Investor's Business Daily
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
Via Benzinga
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
Via Benzinga
GILEAD SCIENCES INC (NASDAQ:GILD) Presents a Compelling Case for Value Investors
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
NAFA Publishes New Fleet Safety Guidebook Aimed at Developing Safety-First Culture in all Organizations
Via News Direct
Xilio Revenue Jumps 246 Percent in Q2
Via The Motley Fool
Topics Intellectual Property
Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
Q2 Rundown: Gilead Sciences (NASDAQ:GILD) Vs Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 112.71
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 09/02/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 141.32B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 141B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.